Late Sodium Current in Atrial Cardiomyocytes Contributes to the Induced and Spontaneous Atrial Fibrillation in Rabbit Hearts.

Journal of Cardiovascular Pharmacology
Yanpeng ChuLin Wu

Abstract

Increased late sodium current (INa) induces long QT syndrome 3 with increased risk of atrial fibrillation (AF). The role of atrial late INa in the induction of AF and in the treatment of AF was determined in this study. AF parameters were measured in isolated rabbit hearts exposed to late INa enhancer and inhibitors. Late INa from isolated atrial and ventricular myocytes were measured using whole-cell patch-clamp techniques. We found that induced-AF by programmed S1S2 stimulation and spontaneous episodes of AF were recorded in hearts exposed to either low (0.1-3 nM) or high (3-10 nM) concentrations of ATX-II (n = 10). Prolongations in atrial monophasic action potential duration at 90% completion of repolarization and effective refractory period by ATX-II (0.1-15 nM) were greater in hearts paced at slow than at fast rates (n = 5-10, P < 0.05). Both endogenous and ATX-II-enhanced late INa density were greater in atrial than that in ventricular myocytes (n = 9 and 8, P < 0.05). Eleclazine and ranolazine reduced AF window and AF burden in association with the inhibition of both endogenous and enhanced atrial late INa with half maximal inhibitory concentrations (IC50) of 1.14 and 9.78, and 0.94 and 8.31 μM, respectively. The IC50s f...Continue Reading

References

Apr 26, 2007·JAMA : the Journal of the American Medical Association·David A MorrowUNKNOWN MERLIN-TIMI 36 Trial Investigators
Oct 22, 2008·Journal of the American College of Cardiology·Takeru MakiyamaMinoru Horie
Nov 19, 2008·Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing·Stephen P SeslarCharles I Berul
Dec 17, 2008·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Lin WuLuiz Belardinelli
Apr 17, 2014·Handbook of Experimental Pharmacology·Charles AntzelevitchLuiz Belardinelli
Dec 3, 2014·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Luiz BelardinelliJohn C Shryock
Jun 21, 2015·Trends in Cardiovascular Medicine·Jonathan C Makielski
Sep 4, 2015·Journal of Cardiovascular Electrophysiology·Juliana Saran CarneiroRichard L Verrier
Nov 12, 2015·Channels·Birgit T Priest, Jeff S McDermott
Aug 5, 2016·Nature Reviews. Cardiology·Stanley Nattel, Dobromir Dobrev
Mar 8, 2017·Annals of Internal Medicine·Peter Zimetbaum
Nov 12, 2017·Pflügers Archiv : European journal of physiology·Shandong YuLin Wu
Oct 26, 2018·Circulation·Ming LeiChristopher L-H Huang
Feb 3, 2019·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Qing ZhangLin Wu
Aug 25, 2019·Heart·Rohan S Wijesurendra, Barbara Casadei
Oct 16, 2019·Circulation. Arrhythmia and Electrophysiology·Pyotr G PlatonovWojciech Zareba
Oct 18, 2019·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Amara Greer-ShortThomas J Hund

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.